Year |
Citation |
Score |
2020 |
Schillebeeckx I, Armstrong JR, Forys JT, Hiken J, Earls J, Flanagan KC, Cui T, Glasscock JI, Messina DN, Duncavage EJ. Analytical Performance of an Immunoprofiling Assay Based on RNA Models. The Journal of Molecular Diagnostics : Jmd. PMID 32036085 DOI: 10.1016/J.Jmoldx.2020.01.009 |
0.415 |
|
2018 |
Rosenbaum JN, Bloom R, Forys JT, Hiken J, Armstrong JR, Branson J, McNulty S, Velu PD, Pepin K, Abel H, Cottrell CE, Pfeifer JD, Kulkarni S, Govindan R, Konnick EQ, et al. Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 29327716 DOI: 10.1038/Modpathol.2017.181 |
0.347 |
|
2015 |
Warrington NM, Sun T, Luo J, McKinstry RC, Parkin PC, Ganzhorn S, Spoljaric D, Albers AC, Merkelson A, Stewart DR, Stevenson DA, Viskochil D, Druley TE, Forys JT, Reilly KM, et al. The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients. Cancer Research. 75: 16-21. PMID 25381154 DOI: 10.1158/0008-5472.Can-14-1891 |
0.303 |
|
2014 |
Brooks MD, Jackson E, Warrington NM, Luo J, Forys JT, Taylor S, Mao DD, Leonard JR, Kim AH, Piwnica-Worms D, Mitra RD, Rubin JB. PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cells. Plos One. 9: e107397. PMID 25203500 DOI: 10.1371/Journal.Pone.0107397 |
0.404 |
|
2014 |
Forys JT, Kuzmicki CE, Saporita AJ, Winkeler CL, Maggi LB, Weber JD. ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis. Cell Reports. 7: 514-26. PMID 24726362 DOI: 10.1016/J.Celrep.2014.03.026 |
0.426 |
|
2011 |
Zhang Y, Forys JT, Miceli AP, Gwinn AS, Weber JD. Identification of DHX33 as a mediator of rRNA synthesis and cell growth. Molecular and Cellular Biology. 31: 4676-91. PMID 21930779 DOI: 10.1128/Mcb.05832-11 |
0.53 |
|
2011 |
Forys JT, Kladney RD, Weber JD. Abstract A40: Investigating the functional response of the ARF tumor suppressor to acute p53 loss Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-A40 |
0.697 |
|
Show low-probability matches. |